IGO (IGO) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Greenbushes delivered strong operational and financial performance, exceeding production plans and maintaining high margins and cash flow, despite lower sales due to shipment timing.
Nova experienced lower nickel output and higher costs due to mine-grade and plant issues, impacting group results.
Kwinana saw improved production post-shutdown, but financials were impacted by inventory build-up, NRV adjustments, and the cessation of Train 2/LHP2 activities.
Forrestania completed mining and transitioned to care and maintenance after its final concentrate sale.
Group underlying EBITDA loss of $79M (excluding Kwinana impairment) due to lower TLEA contribution, reduced sales, lower spodumene prices, FX losses, and inventory adjustments.
Financial highlights
Sales revenue declined 8% quarter-over-quarter to A$131.8M, with YTD revenue at A$275M.
Underlying EBITDA loss of $79M in 2Q25, compared to a $2.9M loss in 1Q25.
Share of net loss from TLEA was $56.7M in 2Q25, down from a $37.1M profit in 1Q25.
Underlying free cash outflow of $6.1M in 2Q25, reversing a $3.6M inflow in 1Q25.
Cash on hand at 31 Dec 2024 was $246.6M, with $720M undrawn debt available.
Outlook and guidance
Greenbushes is expected to continue strong performance, with spodumene production guidance of 1,350–1,550kt and cash cost $320–380/t; CGP3 commissioning remains on track for 2Q FY26.
Nova nickel production guidance for FY25 is 16,000–18,000t, copper 6,250–7,250t, cobalt 550–650t, with cash cost $4.80–5.80/lb Ni; life-of-mine plan to be updated.
Kwinana's future and guidance are under review, with more clarity expected in the next quarterly update; Train 1 sustaining and improvement capex $80–100M.
No TLEA dividends expected in 2H25.
Latest events from IGO
- Net loss of $955M on 37% lower revenue, with impairments and market headwinds impacting results.IGO
H2 20254 Jun 2026 - Revenue and profit fell sharply despite strong production, safety gains, and solid liquidity.IGO
H2 20244 Jun 2026 - Revenue and EBITDA surged, but Greenbushes guidance was lowered amid operational challenges.IGO
Q3 202624 Apr 2026 - Loss after tax improved to AUD 34 million, with stronger Nova EBITDA and cost discipline.IGO
H1 202610 Apr 2026 - AGM revealed major losses, board renewal, and a refocused strategy on battery materials.IGO
AGM 20253 Feb 2026 - Operational strength at Nova and Greenbushes drove higher EBITDA and strong cash flow.IGO
Q2 20263 Feb 2026 - Strong cash flow, safety gains, and resilient core asset performance in FY24.IGO
Q4 20242 Feb 2026 - Lithium-led growth, disciplined returns, and net zero by 2035 drive the refreshed strategy.IGO
Strategy Day 202420 Jan 2026 - Lower prices drove a $2.9M EBITDA loss and 39% revenue drop despite strong Greenbushes output.IGO
Q1 202518 Jan 2026